Classification criteria for rheumatoid arthritis - Time to abandon rheumatoid factor?

Rheumatology

Volumn 46, Issue 5, 2007, Pages 725-726

  Symmons, Deborah P M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPERINUCLEAR FACTOR; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FIBRIN; FILAGGRIN; KERATIN ANTIBODY; METHOTREXATE; PROTEIN ARGININE DEIMINASE; RHEUMATOID FACTOR; VIMENTIN; BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; BONE EROSION; CHEMICAL REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE DURATION; EARLY INTERVENTION; ECHOGRAPHY; EDITORIAL; ENZYME ACTIVITY; FIBROMYALGIA; HUMAN; LUPUS ERYTHEMATOSUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; BLOOD; CLASSIFICATION; IMMUNOLOGY;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; HUMANS; PEPTIDES, CYCLIC; RHEUMATOID FACTOR;

EID: 34347224431     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel418     Document Type: Editorial

References (26)

1. Amett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
2. Harrison BJ, Symmons DP, Barrett EM, Silman AJ. The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. J Rheumatol 1998;25:2324-30.
3. Saraux A, Berthelot JM, Chales G et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 2001;44:2485-91.
4. Dixon WG, Symmons DP. Does early rheumatoid arthritis exist? Best Pract Res Clin Rheumatol 2005;19:37-53.
5. Lunt M, Symmons DP, Silman AJ. An evaluation of the decision tree format of the American College of Rheumatology 1987 classification criteria for rheumatoid arthritis: Performance over five years in a primary care-based prospective study. Arthritis Rheum 2005;52:2277-83.
6. Lard LR, Visser H, Speyer I et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: Comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51.
7. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004;43:906-14.
8. McQueen FM, Stewart N, Crabbe J et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis 1999;58:156-63.
9. McGonagle D, Conaghan PG, O'Connor P et al. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: A controlled magnetic resonance imaging study. Arthritis Rheum 1999;42:1706-11.
10. Wakefield RJ, Gibbon WW, Conaghan PG et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: A comparison with conventional radiography. Arthritis Rheum 2000;43:2762-70.
11. Tunn EJ, Bacon PA. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 1993;32:97-103.
12. Wolfe F, Ross K, Hawley DJ, Roberts FK, Cathey MA. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: A study of 1141 patients. J Rheumatol 1993;20:2005-9.
13. Nienhuis RL, Mandema E. A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor. Ann Rheum Dis 1964;23:302-5.
14. Young BJ, Mallya RK, Leslie RD, Clark Cd, Hamblin TJ. Anti-keratin antibodies in rheumatoid arthritis. Br Med J 1979;2:97-9.
15. Schellekens GA, Visser H, de Jong BA et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:156-63.
16. Klareskog L, Stolt P, Lundberg K eat al. A now model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
17. Mewer D, Coote A, Moore DJ et al. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic saverity of rheumatoid arthritis. Arthritis Res Ther 2006;8;R128.
18. Avouac, J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis 2006;65:845-51.
19. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR. The HLA-DRB1 shared apitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006;54:1117-21.
20. Visser H, le CS, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002;46:357-65.
21. De Rycke L, Peene I, Hoffman IE et al. Rheumatoid factor and anticitruillinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 2004;63:1587-93.
22. van Dongen H, van Akan J, Lard L et al. Probable rheumatoid arthritis methotrexate versus placebo therapy (prompt)-study: indications for a window of opportunity in the treatment of patients with undifferentiated arthritis. Ann Rheum Dis 2006;65(Suppl II), 54. 2006. (Abstract).
23. Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 2006;65:366-71.
24. van Gaalen FA, Linn-Rasker SP, van Venrooij WJ et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study. Arthritis Rheum 2004;50:709-15.
25. Symmons D, Tricker K, Harrison M et al. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs-results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology 2006;45:558-65.
26. Nell VP, Machold KP, Stamm TA et al. Autoantibody profiling as early diagnostic and prognostic tod for rheumatoid arthritis. Ann Rheum Dis 2005;64:1731-6.